According to Coherent Market Insights, the global calcium pantothenate market is estimated to be valued at US$ 258.4 million in 2022 and is expected to exhibit
Evive Biotech has entered into a license agreement with Acrotech Biopharma, a New Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA Inc., to commercialize Ryzneuta™ i.e., Efbemalenograstim alfa in the US.